文献速递白血病

急性髓系白血病中含端粒重复序列的RNA表达失调

Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia.
PubMed 文献 · Blood Adv · 2023-01-01

该研究首次全面检测了初诊急性髓系白血病(AML)、急性淋巴细胞白血病(ALL)、端粒生物学障碍(TBD)患者及健康供者原代造血细胞中的TERRA表达。结果显示TERRA在除AML外的原代造血细胞中均被抑制;在88例AML的第二队列中,TERRA在部分AML亚组中过表达,该亚组还表现为R-loop形成增加、TERT和RNAseH2低表达及体细胞剪接因子突变稀少。在2株AML细胞系中增加RNAseH1表达以耗竭R-loop后,细胞对阿糖胞苷的化疗敏感性增加。

要点

  • TERRA在健康供者、ALL和TBD患者原代造血细胞中均被抑制,与端粒长度无关。
  • 88例AML队列中,TERRA在一部分AML亚组中过表达,伴R-loop形成增加、TERT和RNAseH2低表达。
  • 在2株AML细胞系中耗竭TERRA R-loop可增加对阿糖胞苷的化疗敏感性。

核心结论

  • TERRA在除AML外的原代人类造血细胞中均被抑制,但在低端粒酶活性的一个AML亚组中异常表达。
  • 在2株AML细胞系中减少TERRA R-loop可增加对阿糖胞苷的化疗敏感性。

研究设计与样本

  • 探索性队列研究,检测AML、ALL、TBD患者及健康供者原代人类造血细胞中的TERRA表达。
  • 第二个队列纳入88例AML患者,分析TERRA表达与R-loop形成、TERT、RNAseH2表达及体细胞剪接因子突变的关系。
  • 在2株AML细胞系中通过增加RNAseH1表达诱导R-loop耗竭,评估对阿糖胞苷的化疗敏感性。

主要发现

  • TERRA表达在健康供者、ALL患者和TBD患者的原代人类造血细胞中被抑制,与端粒长度无关,AML除外。
  • 88例AML的第二队列显示,TERRA在部分AML亚组中过表达,该亚组还表现为R-loop形成增加、TERT和RNAseH2低表达及体细胞剪接因子突变稀少。
  • 端粒长度与TERRA表达水平不相关。
  • 在2株AML细胞系中减少TERRA R-loop后,对阿糖胞苷的化疗敏感性增加。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

TERRA (telomeric repeat-containing RNA) is a class of long noncoding RNAs transcribed from subtelomeric and telomeric regions. TERRA binds to the subtelomeric and telomeric DNA-forming R-loops (DNA-RNA hybrids), which are involved in telomere maintenance and telomerase function, but the role of TERRA in human cells is not well characterized. Here, we comprehensively investigated for the first time TERRA expression in primary human hematopoietic cells from an exploratory cohort of patients with acute myeloid leukemia (AML), patients with acute lymphoblastic leukemia (ALL), patients with telomere biology disorder (TBD), and healthy subjects. TERRA expression was repressed in primary human hematopoietic cells, including healthy donors, patients with ALL, and patients with TBD, irrespective of their telomere length, except for AML. A second cohort comprising 88 patients with AML showed that TERRA was overexpressed in an AML subgroup also characterized by higher R-loop formation, low TERT and RNAseH2 expression, and a paucity of somatic splicing factor mutations. Telomere length did not correlate with TERRA expression levels. To assess the role of TERRA R-loops in AML, we induced R-loop depletion by increasing RNAseH1 expression in 2 AML cell lines. Decreased TERRA R-loops in AML cell lines resulted in increased chemosensitivity to cytarabine. Our findings indicate that TERRA is uniformly repressed in primary human hematopoietic cells but abnormally expressed in an AML subset with low telomerase.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Catto LFB, Zanelatto LC, Donaires FS, et al. Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia. Blood Adv. 2023. PMID: 37773887. doi:10.1182/bloodadvances.2023010658

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。